LNWWM
CELGZ

Laird Norton Wetherby Wealth Management’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History

Laird Norton Wetherby Wealth Management’s Portfolio CELGZ Stock Details CELGZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-130
Closed – – 519
2015
Q2 		$0 Buy
+130
New +$333 ﹤0.01% 519

Other funds holding CELGZ

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
FA
FCG Advisors Chatham, New Jersey $425M AUM 12.09% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

Laird Norton Wetherby Wealth Management's CELGZ Position: Q3 2015 in Review

Laird Norton Wetherby Wealth Management sold out of Celgene Corporation Contingent Value Rights (CELGZ) in Q3 2015, closing a stake of 130 shares.

Laird Norton Wetherby Wealth Management first reported a position in CELGZ in Q2 2015 and held it in 1 quarter. The position peaked at $0 in Q2 2015. 25 funds tracked by Wall St. Rank hold CELGZ as of Q3 2015.

  • Laird Norton Wetherby Wealth Management reported no remaining Celgene Corporation Contingent Value Rights position as of Q3 2015 after selling out during the quarter.
  • Laird Norton Wetherby Wealth Management sold 130 Celgene Corporation Contingent Value Rights shares in Q3 2015.
  • Laird Norton Wetherby Wealth Management first reported a position in Celgene Corporation Contingent Value Rights in Q2 2015 and held it in 1 quarter.
  • Laird Norton Wetherby Wealth Management's Celgene Corporation Contingent Value Rights position peaked at $0 in Q2 2015.
  • 25 funds tracked by Wall St. Rank held Celgene Corporation Contingent Value Rights as of Q3 2015.

Based on Laird Norton Wetherby Wealth Management's 13F filing for Q3 2015, filed 12 Nov 2015.